Docetaxel+bevacizumab

2 trials

Sponsors

Tochigi Cancer Center, Kinki University Faculty of Medicine, Nara Hospital

Conditions

Non-small-cell lung cancernon-squamous non-small cell lung cancer

Phase 2

Phase II Study of Docetaxel+Bevacizumab with non-squamous non-small cell lung cancer for patients pretreated with chemotherapy

Active, not recruitingJPRN-UMIN000005077

Tochigi Cancer CenterNon-small-cell lung cancer

Start: 2011-01-01Target: 22Updated: 2026-06-29

A Phase 2 study of Docetaxel and Bevacizumab as the second line treatment for patients with non-squamous non-small cell lung cancer previously treated with platinum-based chemotherapy.

RecruitingJPRN-UMIN000006641

Kinki University Faculty of Medicine, Nara Hospitalnon-squamous non-small cell lung cancer

Start: 2011-11-01Target: 41Updated: 2026-06-29